PECAM1 and chronic obstructive pulmonary disease: Regarding ICS treatment, even though suppression of lung inflammation is the goal of the treatment, we observed relatively decreased Sirt1 and CD31 expression in blood cells from patients with severe COPD (Fig. 5a).